Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial.
- DOI
- 10.3390/diagnostics16111649
- Published
- 2026 May 27
- Container
- Diagnostics (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics16111649,
title = {Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial.},
author = {Kølner-Augustson L and Altraja A and Bendstrup E and Bradding P and Makholm N and Wilson AM and Simonsen U and Hilberg O},
year = {2026},
journal = {Diagnostics (Basel, Switzerland)},
doi = {10.3390/diagnostics16111649},
url = {https://doi.org/10.3390/diagnostics16111649}
}RIS
TY - JOUR TI - Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. AU - Kølner-Augustson L AU - Altraja A AU - Bendstrup E AU - Bradding P AU - Makholm N AU - Wilson AM AU - Simonsen U AU - Hilberg O PY - 2026 JO - Diagnostics (Basel, Switzerland) DO - 10.3390/diagnostics16111649 UR - https://doi.org/10.3390/diagnostics16111649 ER -
APA
L, K., A, A., E, B., P, B., N, M., AM, W., U, S., & O, H. (2026). Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16111649
Source records
- pubmed · retrieved 2026-09-26T21:42:29.801Z